Daub, Marlon F.
HRN: 22-82-84 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/16/2023
METRONIDAZOLE 500MG (TAB)
04/16/2023
04/19/2023
ORAL
500 Mg
Q8
Amoebic Abcess
Waiting Final Action
Indication: Empirical EscalationEmpirical De-escalation Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes